Post-Trial Access
MedaDemo is committed to the ethical continuation of care following clinical trials. Participants who have benefited from investigational therapies during a study may be eligible for continued access after the trial ends, based on medical need, regulatory guidance, and product availability.
Requests for post-trial access are reviewed individually to ensure they meet appropriate clinical and ethical standards.
To initiate a request, please visit our intake portal: